Widespread subclinical cellular changes revealed across a neural-epithelial-vascular complex in choroideremia using adaptive optics.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
13 09 2022
Historique:
received: 21 04 2022
accepted: 12 08 2022
entrez: 13 9 2022
pubmed: 14 9 2022
medline: 16 9 2022
Statut: epublish

Résumé

Choroideremia is an X-linked, blinding retinal degeneration with progressive loss of photoreceptors, retinal pigment epithelial (RPE) cells, and choriocapillaris. To study the extent to which these layers are disrupted in affected males and female carriers, we performed multimodal adaptive optics imaging to better visualize the in vivo pathogenesis of choroideremia in the living human eye. We demonstrate the presence of subclinical, widespread enlarged RPE cells present in all subjects imaged. In the fovea, the last area to be affected in choroideremia, we found greater disruption to the RPE than to either the photoreceptor or choriocapillaris layers. The unexpected finding of patches of photoreceptors that were fluorescently-labeled, but structurally and functionally normal, suggests that the RPE blood barrier function may be altered in choroideremia. Finally, we introduce a strategy for detecting enlarged cells using conventional ophthalmic imaging instrumentation. These findings establish that there is subclinical polymegathism of RPE cells in choroideremia.

Identifiants

pubmed: 36100689
doi: 10.1038/s42003-022-03842-7
pii: 10.1038/s42003-022-03842-7
pmc: PMC9470576
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

893

Subventions

Organisme : NEI NIH HHS
ID : P30 EY026877
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY031360
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY032147
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY032669
Pays : United States

Informations de copyright

© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

Maunther, H. Ein fall von choroideremie. Ber. Nat. med Ver. Innsbr. 2, 191–197 (1872).
Aleman, T. S. et al. Natural history of the central structural abnormalities in choroideremia: a prospective cross-sectional study. Ophthalmology 124, 359–373 (2017).
pubmed: 27986385 doi: 10.1016/j.ophtha.2016.10.022
Kalatzis, V., Hamel, C. P., MacDonald, I. M. & Symposium, F. I. C. R. Choroideremia: towards a therapy. Am. J. Ophthalmol. 156, 433–437.e433 (2013).
pubmed: 23810476 doi: 10.1016/j.ajo.2013.05.009
Pennesi, M. E., Birch, D. G., Duncan, J. L., Bennett, J. & Girach, A. CHOROIDEREMIA: retinal degeneration with an unmet need. Retina 39, 2059 (2019).
pubmed: 31021898 pmcid: 7347087 doi: 10.1097/IAE.0000000000002553
Cameron, J. D., Fine, B. S. & Shapiro, I. Histopathologic observations in choroideremia with emphasis on vascular changes of the uveal tract. Ophthalmology 94, 187–196 (1987).
pubmed: 3574884 doi: 10.1016/S0161-6420(87)33479-7
Foote, K. G. et al. Cone structure persists beyond margins of short-wavelength autofluorescence in choroideremia. IOVS 60, 4931–4942 (2019).
Flannery, J., Bird, A., Farber, D., Weleber, R. & Bok, D. A histopathologic study of a choroideremia carrier. IOVS 31, 229–236 (1990).
Krock, B. L., Bilotta, J. & Perkins, B. D. Noncell-autonomous photoreceptor degeneration in a zebrafish model of choroideremia. PNAS 104, 4600–4605 (2007).
pubmed: 17360570 pmcid: 1810335 doi: 10.1073/pnas.0605818104
Morgan, J. I. et al. High-resolution adaptive optics retinal imaging of cellular structure in choroideremia. IOVS 55, 6381–6397 (2014).
Sun, L. W. et al. Multimodal imaging of photoreceptor structure in choroideremia. PloS ONE 11, e0167526 (2016).
pubmed: 27936069 pmcid: 5147929 doi: 10.1371/journal.pone.0167526
Wavre-Shapton, S. T., Tolmachova, T., da Silva, M. L., Futter, C. E. & Seabra, M. C. Conditional ablation of the choroideremia gene causes age-related changes in mouse retinal pigment epithelium. PloS ONE 8, e57769 (2013).
pubmed: 23460904 pmcid: 3584022 doi: 10.1371/journal.pone.0057769
Syed, N. et al. Evaluation of retinal photoreceptors and pigment epithelium in a female carrier of choroideremia. Ophthalmology 108, 711–720 (2001).
pubmed: 11297488 doi: 10.1016/S0161-6420(00)00643-6
van den Hurk, J. A. et al. Mouse choroideremia gene mutation causes photoreceptor cell degeneration and is not transmitted through the female germline. Hum. Mol. Genet. 6, 851–858 (1997).
pubmed: 9175730 doi: 10.1093/hmg/6.6.851
Jacobson, S. G. et al. Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations. IOVS 47, 4113–4120 (2006).
Rodrigues, M. M. et al. Choroideremia: a clinical, electron microscopic, and biochemical report. Ophthalmology 91, 873–883 (1984).
pubmed: 6089068 doi: 10.1016/S0161-6420(84)34239-7
Syed, R. et al. High-resolution images of retinal structure in patients with choroideremia. IOVS 54, 950–961 (2013).
Tolmachova, T. et al. Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia. J. Clin. Investig. 116, 386–394 (2006).
pubmed: 16410831 pmcid: 1326146 doi: 10.1172/JCI26617
Tolmachova, T. et al. Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type–specific knockout mouse models of choroideremia. IOVS 51, 4913–4920 (2010).
MacDonald, I. M., Russell, L. & Chan, C.-C. Choroideremia: new findings from ocular pathology and review of recent literature. Surv. Ophthalmol. 54, 401–407 (2009).
pubmed: 19422966 pmcid: 2679958 doi: 10.1016/j.survophthal.2009.02.008
Duncan, J. L. Gene Therapy for Choroideremia—Progress and Remaining Questions. JAMA Ophthalmol. 137, 1254–1255 (2019).
pubmed: 31465091 doi: 10.1001/jamaophthalmol.2019.3295
Edwards, T. L. et al. Visual acuity after retinal gene therapy for choroideremia. NEJM 374, 1996–1998 (2016).
pubmed: 27120491 doi: 10.1056/NEJMc1509501
MacLaren, R. E. et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet 383, 1129–1137 (2014).
pubmed: 24439297 pmcid: 4171740 doi: 10.1016/S0140-6736(13)62117-0
Ong, T., Pennesi, M. E., Birch, D. G., Lam, B. L. & Tsang, S. H. Adeno-associated viral gene therapy for inherited retinal disease. Pharm. Res. 36, 34 (2019).
pubmed: 30617669 pmcid: 6534121 doi: 10.1007/s11095-018-2564-5
Jauregui, R. et al. Spectrum of disease severity and phenotype in choroideremia carriers. Am. J. Ophthalmol. 207, 77–86 (2019).
pubmed: 31181178 pmcid: 7579725 doi: 10.1016/j.ajo.2019.06.002
Sieving, P. A., Niffenegger, J. H. & Berson, E. L. Electroretinographic findings in selected pedigrees with choroideremia. Am. J. Ophthalmol. 101, 361–367 (1986).
pubmed: 3953730 doi: 10.1016/0002-9394(86)90832-9
Coussa, R. G. & Traboulsi, E. I. Choroideremia: a review of general findings and pathogenesis. Ophthalmic Genet. 33, 57–65 (2012).
pubmed: 22017263 doi: 10.3109/13816810.2011.620056
Renner, A. B., Fiebig, B. S., Cropp, E., Weber, B. H. & Kellner, U. Progression of retinal pigment epithelial alterations during long-term follow-up in female carriers of choroideremia and report of a novel CHM mutation. Arch. Ophthalmol. 127, 907–912 (2009).
pubmed: 19597113 doi: 10.1001/archophthalmol.2009.123
Bonilha, V. L. et al. Choroideremia: analysis of the retina from a female symptomatic carrier. Ophthalmic Genet. 29, 99–110 (2008).
pubmed: 18766988 pmcid: 3652314 doi: 10.1080/13816810802206499
Dugel, P. U., Zimmer, C. N. & Shahidi, A. M. A case study of choroideremia carrier–Use of multi-spectral imaging in highlighting clinical features. Am. J. Ophthalmol. 2, 18–22 (2016).
Ortiz-Ramirez, G. Y., Villanueva-Mendoza, C., Zenteno Ruiz, J. C., Reyes, M. & Cortés-González, V. Autofluorescence in female carriers with choroideremia: a familial case with a novel mutation in the CHM gene. Ophthalmic Genet. 41, 625–628 (2020).
pubmed: 32835561 doi: 10.1080/13816810.2020.1810283
Roorda, A. & Duncan, J. L. Adaptive optics ophthalmoscopy. Annu. Rev. Vis. Sci. 1, 19–50 (2015).
pubmed: 26973867 pmcid: 4786023 doi: 10.1146/annurev-vision-082114-035357
Suzuki, K. et al. High-resolution retinal imaging reveals preserved cone photoreceptor density and choroidal thickness in female carriers of choroideremia. Ophthalmic Surg. Lasers Imaging Retin. 50, 76–85 (2019).
doi: 10.3928/23258160-20190129-03
Tuten, W. S. et al. Visual function at the atrophic border in choroideremia assessed with adaptive optics microperimetry. Ophthalmol. Retin. 3, 888–899 (2019).
doi: 10.1016/j.oret.2019.05.002
Tam, J., Liu, J., Dubra, A. & Fariss, R. In vivo imaging of the human retinal pigment epithelial mosaic using adaptive optics enhanced indocyanine green ophthalmoscopy. IOVS 57, 4376–4384 (2016).
Jung, H. et al. Longitudinal adaptive optics fluorescence microscopy reveals cellular mosaicism in patients. JCI Insight 4, e124904 (2019).
Jung, H., Liu, T., Liu, J., Huryn, L. A. & Tam, J. Combining multimodal adaptive optics imaging and angiography improves visualization of human eyes with cellular-level resolution. Commun. Biol. 1, 1–9 (2018).
doi: 10.1038/s42003-018-0190-8
Bower, A. J. et al. Integrating adaptive optics-SLO and OCT for multimodal visualization of the human retinal pigment epithelial mosaic. Biomed. Opt. Express 12, 1449–1466 (2021).
pubmed: 33796365 pmcid: 7984802 doi: 10.1364/BOE.413438
Liu, Z., Kocaoglu, O. P. & Miller, D. T. 3D imaging of retinal pigment epithelial cells in the living human retina. IOVS 57, OCT533–OCT543 (2016).
Liu, Z., Kurokawa, K., Hammer, D. X. & Miller, D. T. In vivo measurement of organelle motility in human retinal pigment epithelial cells. Biomed. Opt. Express 10, 4142–4158 (2019).
pubmed: 31453000 pmcid: 6701538 doi: 10.1364/BOE.10.004142
Liu, T., Jung, H., Liu, J., Droettboom, M. & Tam, J. Noninvasive near infrared autofluorescence imaging of retinal pigment epithelial cells in the human retina using adaptive optics. Biomed. Opt. Express 8, 4348–4360 (2017).
pubmed: 29082069 pmcid: 5654784 doi: 10.1364/BOE.8.004348
Liu, J., Han, Y.-J., Liu, T., Aguilera, N. & Tam, J. Spatially aware dense-linkNet based regression improves fluorescent cell detection in adaptive optics ophthalmic images. IEEE J. Biomed. Health Inf. 24, 3520–3528 (2020).
doi: 10.1109/JBHI.2020.3004271
Giannini, J. P., Lu, R., Bower, A. J., Fariss, R. & Tam, J. Visualizing retinal cells with adaptive optics imaging modalities using a translational imaging framework. Biomed. Opt. Express 13, 3042–3055 (2022).
pubmed: 35774328 pmcid: 9203084 doi: 10.1364/BOE.454560
Curcio, C. A., Sloan, K. R., Kalina, R. E. & Hendrickson, A. E. Human photoreceptor topography. J Comparative Neurology 292, 497–523 (1990).
Li, J. et al. Persistent Dark Cones in Oligocone Trichromacy Revealed by Multimodal Adaptive Optics Ophthalmoscopy. Front. Aging Neurosci. 13, 88 (2021).
Rossetti, L. et al. Compass: clinical evaluation of a new instrument for the diagnosis of glaucoma. PLoS ONE 10, e0122157 (2015).
pubmed: 25807241 pmcid: 4373771 doi: 10.1371/journal.pone.0122157
Scoles, D., Sulai, Y. N. & Dubra, A. In vivo dark-field imaging of the retinal pigment epithelium cell mosaic. Biomed. Opt. Express 4, 1710–1723 (2013).
pubmed: 24049692 pmcid: 3771842 doi: 10.1364/BOE.4.001710
Liu, T. et al. Photoreceptor and Retinal Pigment Epithelium Relationships in Eyes With Vitelliform Macular Dystrophy Revealed by Multimodal Adaptive Optics Imaging. IOVS 63, 27–27 (2022).
Ach, T. et al. Lipofuscin redistribution and loss accompanied by cytoskeletal stress in retinal pigment epithelium of eyes with age-related macular degeneration. IOVS 56, 3242–3252 (2015).
Gambril, J. A. et al. Quantifying retinal pigment epithelium dysmorphia and loss of histologic autofluorescence in age-related macular degeneration. IOVS 60, 2481–2493 (2019).
Rossi, E. A. et al. In vivo imaging of retinal pigment epithelium cells in age related macular degeneration. Biomed. Opt. Express 4, 2527–2539 (2013).
pubmed: 24298413 pmcid: 3829547 doi: 10.1364/BOE.4.002527
Chen, M. et al. Retinal pigment epithelial cell multinucleation in the aging eye–a mechanism to repair damage and maintain homoeostasis. Aging Cell 15, 436–445 (2016).
pubmed: 26875723 pmcid: 4854907 doi: 10.1111/acel.12447
MacDonald, I., Chen, M., Addison, D., Mielke, B. & Nesslinger, N. Histopathology of the retinal pigment epithelium of a female carrier of choroideremia. Can. J. Ophthalmol. 32, 329–333 (1997).
pubmed: 9276121
Stevanovic, M., Cehajic Kapetanovic, J., Jolly, J. K. & MacLaren, R. E. A distinct retinal pigment epithelial cell autofluorescence pattern in choroideremia predicts early involvement of overlying photoreceptors. Acta Ophthalmol. 98, e322–e327 (2020).
pubmed: 31736270 doi: 10.1111/aos.14281
Fischer, M. D. et al. Efficacy and safety of retinal gene therapy using adeno-associated virus vector for patients with choroideremia: a randomized clinical trial. JAMA Ophthalmol. 137, 1247–1254 (2019).
pubmed: 31465092 pmcid: 6865291 doi: 10.1001/jamaophthalmol.2019.3278
MacDonald, I. M. Lessons learned from research on choroideremia. Ophthalmic Genet. 43, 354–361 (2022).
Dubra, A. & Sulai, Y. Reflective afocal broadband adaptive optics scanning ophthalmoscope. Biomed. Opt. Express 2, 1757–1768 (2011).
pubmed: 21698035 pmcid: 3114240 doi: 10.1364/BOE.2.001757
Scoles, D. et al. In vivo imaging of human cone photoreceptor inner segments. IOVS 55, 4244–4251 (2014).
Dubra, A. & Harvey, Z. In WBIR. 60–71 (Springer, 2010).
Kocaoglu, O. P. et al. Adaptive optics optical coherence tomography with dynamic retinal tracking. Biomed. Opt. Express 5, 2262–2284 (2014).
pubmed: 25071963 pmcid: 4102363 doi: 10.1364/BOE.5.002262
Bennett, A. & Rabbetts, R. Proposals for new reduced and schematic eyes. OPO: J. Br. Coll. Ophthalmic Opticians (Optometrists) 9, 228–230 (1989).
Liu, J., Jung, H., Dubra, A. & Tam, J. Automated photoreceptor cell identification on nonconfocal adaptive optics images using multiscale circular voting. IOVS 58, 4477–4489 (2017).
Duncan, J. L. et al. High-resolution imaging with adaptive optics in patients with inherited retinal degeneration. IOVS 48, 3283–3291 (2007).
Rodieck, R. The density recovery profile: a method for the analysis of points in the plane applicable to retinal studies. Vis. Neurosci. 6, 95–111 (1991).
pubmed: 2049333 doi: 10.1017/S095252380001049X
Turpin, A., Artes, P. H. & McKendrick, A. M. The Open Perimetry Interface: an enabling tool for clinical visual psychophysics. J. Vis. 12, 22–22 (2012).
pubmed: 23104815 doi: 10.1167/12.11.22
Chang, W., Cheng, J., Allaire, J., Xie, Y. & McPherson, J. Shiny: web application framework for R. R. Package Vers. 1, 2017 (2017).
Pfau, M. et al. Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials. Prog. Retin. Eye Res. 82, 100907 (2021).
pubmed: 33022378 doi: 10.1016/j.preteyeres.2020.100907
Fuchsjäger-Mayrl, G. et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. IOVS 45, 834–839 (2004).
Maric, D. et al. Whole-brain tissue mapping toolkit using large-scale highly multiplexed immunofluorescence imaging and deep neural networks. Nat. Commun. 12, 1–12 (2021).
doi: 10.1038/s41467-021-21735-x
Machado, F. B. et al. 5meCpG epigenetic marks neighboring a primate-conserved core promoter short tandem repeat indicate X-chromosome inactivation. PloS ONE 9, e103714 (2014).
pubmed: 25078280 pmcid: 4117532 doi: 10.1371/journal.pone.0103714

Auteurs

Nancy Aguilera (N)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Tao Liu (T)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Andrew J Bower (AJ)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Joanne Li (J)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Sarah Abouassali (S)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Rongwen Lu (R)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

John Giannini (J)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Maximilian Pfau (M)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Chelsea Bender (C)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Margery G Smelkinson (MG)

National Institute of Allergy and Infectious Disease, Research Technologies Branch, National Institutes of Health, Bethesda, MD, USA.

Amelia Naik (A)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Bin Guan (B)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Owen Schwartz (O)

National Institute of Allergy and Infectious Disease, Research Technologies Branch, National Institutes of Health, Bethesda, MD, USA.

Andrei Volkov (A)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Alfredo Dubra (A)

Department of Ophthalmology, Stanford University, Palo Alto, CA, USA.

Zhuolin Liu (Z)

Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD, USA.

Daniel X Hammer (DX)

Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD, USA.

Dragan Maric (D)

National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Robert Fariss (R)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Robert B Hufnagel (RB)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Brett G Jeffrey (BG)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Brian P Brooks (BP)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Wadih M Zein (WM)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Laryssa A Huryn (LA)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Johnny Tam (J)

National Eye Institute, National Institutes of Health, Bethesda, MD, USA. johnny@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH